NCT04768803 Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and/or Overweight, and/or Obesity Status UNKNOWN Phase N/A
NCT04697381 Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS Status COMPLETED Phase PHASE3
NCT04526379 Study of Emotion and Cognition Abilities of Children With PWS and Proposition of an Innovative Remediation Status COMPLETED Phase NA
NCT04484051 Growth Hormone Study in Adults With Prader-Willi Syndrome Status NOT_YET_RECRUITING Phase N/A
NCT04283578 Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome Status COMPLETED Phase PHASE3
NCT04257929 A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension Status COMPLETED Phase PHASE2
NCT04150991 Fiber Intervention on Gut Microbiota in Children With Prader-Willi Syndrome Status COMPLETED Phase NA
NCT04066088 Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome Status WITHDRAWN Phase PHASE4
NCT03858023 Therapeutic Effects of Hippotherapy in Children With Prader-Willi Syndrome Status UNKNOWN Phase NA
NCT03848481 CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS) Status TERMINATED Phase PHASE2
NCT03836300 Parent and Infant Inter(X)Action Intervention (PIXI) Status ENROLLING_BY_INVITATION Phase NA